K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

0
Player Avatar withoutlimits (84.28) Submitted: 1/10/2012 9:31:57 PM : Outperform Start Price: $1.41 KV-A Score: -41.84

Maybe.............

Featured Broker Partners


Advertisement